Darbepoetin alfa to reduce transfusion episodes in infants with haemolytic disease of the fetus and newborn who are treated with intrauterine transfusions in the Netherlands: an open-label, single-centre, phase 2, randomised, controlled trial
Autor: | Ree, Isabelle M C *, de Haas, Masja, van Geloven, Nan, Juul, Sandra E, de Winter, Derek, Verweij, E J T, Oepkes, Dick, van der Bom, Johanna G, Lopriore, Enrico |
---|---|
Zdroj: | In The Lancet Haematology December 2023 10(12):e976-e984 |
Databáze: | ScienceDirect |
Externí odkaz: |